MedTrace Logo

Primary Aldosteronism LC-MS/MS-specific Cutoffs

NCT05959863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 396

Last updated 2024-12-16

No results posted yet for this study

Summary

Aims to evaluation the LC-MS/MS-specific cutoffs of PA screening and CCT test.

Conditions

  • Primary Aldosteronism

Interventions

DIAGNOSTIC_TEST

Captopril Challenge Test

Patients received 50 mg captopril orally in the morning after sitting or standing for at least two hours. PAC and PRC were measured using mass spectrometry two hours after administration of capopril.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Qifu Li · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959863 on ClinicalTrials.gov